These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8403530)
1. Anti-arrhythmic effects of a new calcium antagonist, monatepil, AJ-2615, in experimental arrhythmic models [corrected]. Yamamoto T; Hosoki K; Karasawa T Clin Exp Pharmacol Physiol; 1993; 20(7-8):497-500. PubMed ID: 8403530 [TBL] [Abstract][Full Text] [Related]
2. Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats. Yamamoto T; Nakatsuji K; Hosoki K; Karasawa T Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):673-8. PubMed ID: 8306512 [TBL] [Abstract][Full Text] [Related]
3. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil. Sugimoto T; Hosoki K; Karasawa T J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365 [TBL] [Abstract][Full Text] [Related]
4. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats. Yamamoto T; Hosoki K; Kikuta C; Karasawa T Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969 [TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug. Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system. Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem. Yoshidomi M; Sukamoto T; Morita T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1056-9. PubMed ID: 6890826 [TBL] [Abstract][Full Text] [Related]
8. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers. Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of the new calcium antagonist AJ-2615 on progression of atherosclerosis in cholesterol-fed rabbits. Minato H; Ikeno A; Yamada T; Kato H; Zushi K; Kurokawa M; Masuda Y; Hosoki K; Karasawa T J Cardiovasc Pharmacol; 1993 Apr; 21(4):663-9. PubMed ID: 7681914 [TBL] [Abstract][Full Text] [Related]
11. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals. Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817 [TBL] [Abstract][Full Text] [Related]
12. Reperfusion-induced arrhythmias in the conscious rat: a comparative study with three calcium antagonists. Kinoshita K; Mitani A; Hearse DJ; Braimbridge MV; Manning AS J Surg Res; 1989 Aug; 47(2):166-72. PubMed ID: 2755121 [TBL] [Abstract][Full Text] [Related]
13. Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia. Lim SH; Anantharaman V; Teo WS Resuscitation; 2002 Feb; 52(2):167-74. PubMed ID: 11841884 [TBL] [Abstract][Full Text] [Related]
14. New therapeutic trends in calcium antagonism. Are they meaningful? Nayler WG Am J Hypertens; 1994 Oct; 7(10 Pt 2):126S-130S. PubMed ID: 7826562 [TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606 [TBL] [Abstract][Full Text] [Related]
16. The comparative effects of calcium channel blockers in an experimental colitis model in rats. Zeytunlu M; Korkut M; Akgün E; Firat O; Aynaci M; Içöz G; Kiliç M; Ersin S; Ozütemiz O Turk J Gastroenterol; 2004 Dec; 15(4):243-9. PubMed ID: 16249979 [TBL] [Abstract][Full Text] [Related]
17. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys. Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692 [TBL] [Abstract][Full Text] [Related]
18. The potential synergistic effect of calcium channel blockers and alpha-tocopherol on gastric mucosal injury induced by ischaemia-reperfusion. al-Dohayan AD; al-Tuwaijri AS Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1107-10. PubMed ID: 8944374 [TBL] [Abstract][Full Text] [Related]
19. [Anti-arrhythmia effects of calcium antagonists]. Gülker H; Ketteler T Z Kardiol; 1989; 78 Suppl 5():49-54. PubMed ID: 2698564 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of monatepil, a new calcium antagonist, in the treatment of essential hypertension. Ishii M; Iimura O; Yoshinaga K; Abe K; Inagaki Y; Yagi S; Kuramoto K; Kajiwara N; Saruta T; Kuramochi M Am J Hypertens; 1994 Oct; 7(10 Pt 2):141S-145S. PubMed ID: 7826564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]